Kariya, Shin
Shimizu, Yasushi
Hanai, Nobuhiro
Yasumatsu, Ryuji
Yokota, Tomoya
Fujii, Takashi
Tsukahara, Kiyoaki
Yoshida, Masafumi
Hanyu, Kenji
Ueda, Tsutomu
Hirakawa, Hitoshi
Takahashi, Shunji
Ono, Takeharu
Sano, Daisuke
Yamauchi, Moriyasu
Watanabe, Akihito
Omori, Koichi
Yamazaki, Tomoko
Monden, Nobuya
Kudo, Naomi
Arai, Makoto
Yonekura, Shuji
Asakage, Takahiro
Fujiwara, Akinori
Yamada, Takayuki
Homma, Akihiro http://orcid.org/0000-0003-1488-0646
Funding for this research was provided by:
Bristol-Myers Squibb
Ono Pharmaceutical Co., Ltd.
Article History
Received: 22 December 2020
Accepted: 13 March 2021
First Online: 8 April 2021
Declarations
:
: N. Hanai, K. Omori, and A. Homma report grants from Bristol-Myers Squibb K.K. and Ono Pharmaceutical Co., Ltd. during the conduct of the study. S. Takahashi reports grants and personal fees from AstraZeneca, Bayer, Bristol-Myers Squibb K.K., Chugai Pharma, MSD, and Ono Pharmaceutical Co., Ltd. during the conduct of the study. K. Tsukahara reports personal fees from Bristol-Myers Squibb K.K. and Ono Pharmaceutical Co., Ltd. during the conduct of the study. T. Ueda reports grant from Ono Pharmaceutical Co., Ltd. during the conduct of the study. T. Yamazaki reports grants from AstraZeneca K.K., Bristol-Myers Squibb K.K. and Ono Pharmaceutical Co., Ltd. during the conduct of the study. R. Yasumatsu reports grants from Ono Pharmaceutical Co., Ltd. during the conduct of the study. T. Yokota reports advisory role for Merck Biopharma and personal fees from Bristol-Myers Squibb K.K, Merck Biopharma, and Ono Pharmaceutical Co., Ltd. during the conduct of the study. A. Fujiwara is an employee of Ono Pharmaceutical Co., Ltd. T. Yamada is an employee of Bristol-Myers Squibb K.K. M. Arai, T. Asakage, T. Fujii, K. Hanyu, H. Hirakawa, S. Kariya, N. Kudo, N. Monden, T. Ono, D. Sano, Y. Shimizu, A. Watanabe, M. Yamauchi, S. Yonekura, and M. Yoshida have nothing to disclose during the conduct of the study.